(Q47308356)

13 January 2018

title

Atopic dermatitis: New therapeutic considerations (English)

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

26 October 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

26 October 2022

author name string

J. M. Hanifin

1

1 reference

PubMed ID

1677014

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677014

26 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

13 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:019096229170165X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

https://api.elsevier.com/content/article/PII:019096229170165X?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Journal of the American Academy of Dermatology

26 October 2022

published in

1 reference

13 January 2018

volume

24

1 reference

13 January 2018

issue

6 Pt 2

1 reference

13 January 2018

page(s)

1097-1101

1 reference

13 January 2018

Increased Plasma Histamine Concentrations after Food Challenges in Children with Atopic Dermatitis

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

The role of antihistamines in atopic dermatitis

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Mechanism of action of antipruritic drugs

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Treatment of itching in atopic eczema with antihistamines with a low sedative profile

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Azelastine inhibits IgE-mediated human basophil histamine release

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Mechanism of inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: effect of tranilast on the release of arachidonic acid and its metabolites

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Inhibition of hypersensitivity reactions by a new drug, N(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′)

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Theophylline ethylenediamine as an antipruritic agent

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Increased leukocyte sensitivity to phosphodiesterase inhibitors in atopic dermatitis: Tachyphylaxis after theophylline therapy

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

Thymopentin therapy reduces the clinical severity of atopic dermatitis

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0190-9622(91)70165-X

26 October 2022

Identifiers

0 references

PubMed ID

1677014

1 reference

13 January 2018